Tag: FDA approvals
April 29, 2018
5 Top Weekly NASDAQ Biotech Stocks: Eleven Biotherapeutics Up 45 Percent
Eleven Biotherapeutics, EyePoint Pharmaceuticals, Avid Bioservices, Cerecor and Celldex were last week's top gainers on the NASDAQ.
April 24, 2018
Pharmaceutical Update: Q1 in Review
What happened in Q1 2018 for the pharma industry? Here's a look back at some of the quarter's biggest news...
April 1, 2018
5 Top NASDAQ Biotech Stocks: Cardiome on Top
Cardiome, Avid, XBiotech, Fennec and Compugen were last week's five top-gaining NASDAQ biotech stocks. See what moved their share prices.
March 18, 2018
5 Top NASDAQ Biotech Stocks: Second Sight Medical on Top
Second Sight, Juniper, Athersys, Aptose and ArQule were last week's five top-gaining NASDAQ biotech stocks. See what moved their share...
March 13, 2018
“China Will Become the Biggest Oncology Market in the World Over the Next 20 Years,” Says Chi-Med CEO Christian Hogg
Chi-Med, a China-based biopharmaceutical company, is making a name for itself within the oncology field at a global scale. February 15, 2018
AMAG Pharmaceuticals Announces FDA Approval of Makena
AMAG Pharmaceuticals (NASDAQ:AMAG) today announced that the U.S. Food and Drug Administration (FDA) approved the Makena® subcutaneous auto-injector drug-device combination...
February 13, 2018